| 摘要 |
<p>The present invention relates to nucleosidic phosphoantigens for the treatment of the human or animal body by therapy. The invention also relates to a method for stimulating V³9V´2 T cell-mediated immune response, which comprises the step of administering to a subject in need thereof a therapeutically effective amount of nucleosidic phosphoantigens.</p> |
